Mesa Laboratories IncNASDAQ:MLAB
- LAST PRICE99.6200
- TODAY'S CHANGE (%)-1.5200 (-1.5029%)
- Bid / Lots40.0500/ 2
- Ask / Lots160.1900/ 2
- Open / Previous Close101.0100 / 101.1400
- Day Range
- 52 Week Range
- Volume31,078
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MLAB |
|---|---|---|
| 09:32 ET | 123 | 101.01 |
| 09:36 ET | 275 | 100.32 |
| 09:56 ET | 200 | 100.38 |
| 09:59 ET | 100 | 100.495 |
| 10:42 ET | 100 | 101.545 |
| 10:44 ET | 113 | 102 |
| 10:57 ET | 100 | 102.6 |
| 11:00 ET | 400 | 103.01 |
| 11:02 ET | 405 | 102.5 |
| 11:38 ET | 858 | 102.375 |
| 11:40 ET | 200 | 101.35 |
| 11:42 ET | 200 | 101.6 |
| 11:49 ET | 850 | 102.45 |
| 11:51 ET | 200 | 102.8 |
| 11:54 ET | 100 | 102.55 |
| 11:58 ET | 198 | 102.95 |
| 12:20 ET | 300 | 103.32 |
| 12:50 ET | 200 | 102.38 |
| 01:06 ET | 300 | 102.38 |
| 01:24 ET | 100 | 102.305 |
| 01:26 ET | 200 | 102.11 |
| 01:33 ET | 400 | 102.49 |
| 01:46 ET | 100 | 102.92 |
| 02:08 ET | 100 | 102.02 |
| 02:26 ET | 100 | 101.535 |
| 02:27 ET | 200 | 101.44 |
| 02:36 ET | 600 | 100.1 |
| 02:47 ET | 200 | 100.42 |
| 03:03 ET | 200 | 100.14 |
| 03:23 ET | 200 | 99.67 |
| 03:34 ET | 100 | 99.98 |
| 03:52 ET | 100 | 99.62 |
Apr 8, 2024
MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES, from 8:00AM ET on Monday Apr 08, 2024 by Dow Jones
8:00AM ET on Monday Apr 08, 2024 by Dow Jones
Apr 4, 2024
MESA LABS DECLARES QUARTERLY DIVIDEND, from 6:24PM ET on Thursday Apr 04, 2024 by Dow Jones
6:24PM ET on Thursday Apr 04, 2024 by Dow JonesDJ Mesa Labs Is Maintained at Outperform by Evercore ISI Group, from 12:59PM ET on Thursday Apr 04, 2024 by Dow Jones
12:59PM ET on Thursday Apr 04, 2024 by Dow Jones
Apr 2, 2024
Apr 1, 2024
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024, from 10:27AM ET on Monday Apr 01, 2024 by Dow Jones
10:27AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mesa Laboratories Inc | 545.6M | 568.8x | --- |
Castle Biosciences Inc | 519.7M | -8.9x | --- |
SI-BONE Inc | 625.4M | -13.5x | --- |
Silk Road Medical Inc | 684.0M | -12.1x | --- |
IRadimed Corp | 512.5M | 29.9x | +21.02% |
Treace Medical Concepts Inc | 706.1M | -13.8x | --- |
Company Information
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
Contact Information
- Headquarters
- 12100 W 6th AveLAKEWOOD, United States 80228-1252
- Phone
- 303-987-8000
- Fax
- 303-987-8989
Executives
- Chairman of the Board
- John Sullivan
- President, Chief Executive Officer, Director
- Gary Owens
- Chief Financial Officer, Vice President
- John Sakys
- Senior Vice President - Continuous Improvement
- Brian Archbold
- Lead Independent Director
- Shiraz Ladiwala
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $545.6M |
|---|---|
Revenue (TTM) | $212.9M |
Shares Outstanding | 5.4M |
Dividend Yield | 0.64% |
Annual Dividend Rate | 0.6400 USD |
Ex-Dividend Date | 05-31-24 |
Pay Date | 06-14-24 |
Beta | 0.83 |
EPS | $0.18 |
Book Value | $73.28 |
P/E Ratio | 568.8x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | 15.5x |
Operating Margin | -0.13% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
